Jonas Becker Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty University of Heidelberg Biography Publications Institution JoVE Articles Jonas Becker has not added a biography. If you are Jonas Becker and would like to personalize this page please email our Author Liaison for assistance. Publications Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine Learning Pathogens (Basel, Switzerland). Jul, 2022 | Pubmed ID: 35890005 Right on Target: The Next Class of Efficient, Safe, and Specific RNAi Triggers Molecular Therapy. Nucleic Acids. Jun, 2022 | Pubmed ID: 35505965 Ex vivo and In vivo Suppression of SARS-CoV-2 with Combinatorial AAV/RNAi Expression Vectors Molecular Therapy : the Journal of the American Society of Gene Therapy. 05, 2022 | Pubmed ID: 35038579 Blasticidin S Inhibits Mammalian Translation and Enhances Production of Protein Encoded by Nonsense MRNA Nucleic Acids Research. 07, 2021 | Pubmed ID: 34157102 5-azacytidine Inhibits Nonsense-mediated Decay in a MYC-dependent Fashion EMBO Molecular Medicine. Dec, 2014 | Pubmed ID: 25319547 Telaprevir is a Substrate and Moderate Inhibitor of P-glycoprotein, a Strong Inductor of ABCG2, but Not an Activator of PXR in Vitro International Journal of Antimicrobial Agents. Feb, 2014 | Pubmed ID: 24332840 Cisplatin, Oxaliplatin, and Carboplatin Unequally Inhibit in Vitro MRNA Translation Toxicology Letters. Feb, 2014 | Pubmed ID: 24275384 Isolement de vecteurs de thérapie génique de nouvelle génération par l’ingénierie, le codage à barres et le criblage de variantes de capside du virus adéno-associé (AAV) Kleopatra Rapti1,2, Olena Maiakovska1,2, Jonas Becker1,2, Joanna Szumska1,2, Margarita Zayas1,2, Felix Bubeck1,2, Jixin Liu1,2, Emma Gerstmann1,2, Chiara Krämer1,2, Ellen Wiedtke1,2, Dirk Grimm1,2,3,4,5 1Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, University of Heidelberg, 2BioQuant Center, BQ0030, University of Heidelberg, 3Cluster of Excellence CellNetworks, 4German Center for Infection Research (DZIF), 5German Center for Cardiovascular Research (DZHK) JoVE 64389 Bioengineering
Isolement de vecteurs de thérapie génique de nouvelle génération par l’ingénierie, le codage à barres et le criblage de variantes de capside du virus adéno-associé (AAV) Kleopatra Rapti1,2, Olena Maiakovska1,2, Jonas Becker1,2, Joanna Szumska1,2, Margarita Zayas1,2, Felix Bubeck1,2, Jixin Liu1,2, Emma Gerstmann1,2, Chiara Krämer1,2, Ellen Wiedtke1,2, Dirk Grimm1,2,3,4,5 1Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, University of Heidelberg, 2BioQuant Center, BQ0030, University of Heidelberg, 3Cluster of Excellence CellNetworks, 4German Center for Infection Research (DZIF), 5German Center for Cardiovascular Research (DZHK) JoVE 64389 Bioengineering